53
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Nicotine for Psychiatric Disease: From Nuisance to Novel Treatment?

&
Pages 1217-1220 | Published online: 06 Jul 2015

References

  • Bruijnzeel AW . Tobacco addiction and the dysregulation of brain stress systems. Neurosci. Biobehav. Rev.36 (5), 1418–41 (2012).
  • Borovikova LV , IvanovaS, ZhangMet al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature405 (6785), 458–462 (2000).
  • Gonzalez-Burgos G , ChoRY, LewisDA. Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia. Biol. Psychiatry3, S0006–S3223 (2015).
  • Paz D , TarditoS, AtzoriM, TsengKY. Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology. Eur. Neuropsychopharmacol.18 (11), 773–786 (2008).
  • Reichel JM , NisselS, Rogel-SalazarGet al. Distinct behavioral consequences of short-term and prolonged GABAergic depletion in prefrontal cortex and dorsal hippocampus. Front. Behav. Neurosci.8, 452 (2015).
  • Faravelli C , Lo SauroC, LelliLet al. The role of life events and HPA axis in anxiety disorders: a review. Curr. Pharm. Des.18 (35), 5663–74 (2012).
  • Jones KA , ThomsenC. The role of the innate immune system in psychiatric disorders. Mol. Cell. Neurosci.53, 52–62 (2013).
  • Potvin S , StipE, SepehryAA, GendronA, BahR, KouassiE. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol. Psychiatry63 (8), 801–808 (2008).
  • Sukoff Rizzo SJ , NealSJ, HughesZAet al. Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Transl. Psychiatry2, e199 (2012).
  • Gibb J , HayleyS, GandhiR, PoulterMO, AnismanH. Synergistic and additive actions of a psychosocial stressor and endotoxin challenge: circulating and brain cytokines, plasma corticosterone and behavioral changes in mice. Brain Behav. Immun.22 (4), 573–589 (2008).
  • Li X , Wilder-SmithCH, KanME, LuJ, CaoY, WongRK. Combat-training stress in soldiers increases S100B, a marker of increased blood-brain-barrier permeability, and induces immune activation. Neuro. Endocrinol. Lett.35 (1), 58–63 (2014).
  • Xu N , LiX, ZhongY. Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders. Med. Inflamm.2015, 531518 (2015).
  • Beattie EC , StellwagenD, MorishitaWet al. Control of synaptic strength by glial TNFalpha. Science295 (5563), 2282–2285 (2002).
  • Garcia-Oscos F , SalgadoH, HallSet al. The stress-induced cytokine interleukin-6 decreases the inhibition/excitation ratio in the rat temporal cortex via trans-signaling. Biol. Psychiatry71 (7), 574–582 (2012).
  • Atzori M , Garcia-OscosF, MendezJA. Role of IL-6 in the etiology of hyperexcitable neuropsychiatric conditions: experimental evidence and therapeutic implications. Future Med. Chem.4 (17), 2177–92 (2012).
  • Razani-Boroujerdi S , BehlM, HahnFF, Pena-PhilippidesJC, HuttJ, SoporiML. Role of muscarinic receptors in the regulation of immune and inflammatory responses. J. Neuroimmunol.194 (1–2), 83–88 (2008).
  • Pavlov VA , TraceyKJ. Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochem. Soc. Trans.34 (6), 1037–1040 (2006).
  • Thomsen MS , MikkelsenJD. The α7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-α release from microglia. J. Neuroimmunol.251 (1–2), 65–72 (2012).
  • Garcia-Oscos F , PeñaD, HousiniMet al. Vagal nerve stimulation blocks interleukin 6-dependent synaptic hyperexcitability induced by lipopolysaccharide-induced acute stress in the rodent prefrontal cortex. Brain Behav. Immun.43, 149–158 (2015).
  • Arias HR , BhumireddyP, BouzatC. Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors. Int. J. Biochem. Cell Biol.38 (8), 1254–1276 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.